Return to Article Details The most bothersome lower urinary tract symptom affecting quality of life using international prostate symptom score in patients with benign prostate hyperplasia Download Download PDF

Validation errors:

Failed to locate the main schema resource at 'https://www.crossref.org/schemas/crossref4.3.6.xsd'.

Invalid XML:

<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1746978607</doi_batch_id>
    <timestamp>20250511155007000</timestamp>
    <depositor>
      <depositor_name>Nigerian Medical Association, Akwa Ibom State Branch</depositor_name>
      <email_address>info@ibommedicaljournal.org</email_address>
    </depositor>
    <registrant>Nigerian Medical Association, Akwa Ibom State Branch</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Ibom Medical Journal</full_title>
        <abbrev_title>Ibom Med J</abbrev_title>
        <issn media_type="electronic">2735-9964</issn>
        <issn media_type="print">1597-7188</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>04</month>
          <day>01</day>
          <year>2025</year>
        </publication_date>
        <journal_volume>
          <volume>18</volume>
        </journal_volume>
        <issue>2</issue>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" publication_type="full_text" metadata_distribution_opts="any" language="en">
        <titles>
          <title>Current status on M. pneumoniae: Clinical Features and Management Strategies</title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first">
            <surname>Asit K</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Bragadeeshwaran N</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Janhavi MS</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Shamina S</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Lavanya SV</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Suria P</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Muthu PP</surname>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xml:lang="en">
          <jats:p>Background: The COVID-19 pandemic has significantly impacted Mycoplasma pneumoniae (MP), leading to a decline in prevalence and delayed resurgence. The rise of macrolide-resistant M. pneumoniae complicates treatment, necessitating alternative antibiotics.&#13;
Aim: This review examines the impact of COVID-19 on M. pneumoniae (MP) epidemiology, rising macrolide resistance, and evolving treatment challenges. It highlights advanced diagnostics, alternative antibiotics, and future research needs for predictive biomarkers and novel therapies. Continuous surveillance and adaptive strategies are crucial for optimizing MP infection management in a post-pandemic world.&#13;
Methods: A comprehensive review of recent literature was conducted, focusing on epidemiological trends, antimicrobial resistance patterns, diagnostic innovations, and treatment strategies for MP infections. Data were extracted from peer-reviewed journals, clinical studies, and global health reports to provide an updated perspective on the evolving landscape of MP infections.&#13;
Results: M. pneumoniae infections, which declined during COVID-19 due to non-pharmaceutical interventions, have resurged post-pandemic due to macrolide-resistant infections. Rapid molecular diagnostic tools and predictive biomarkers are needed to improve treatment outcomes and optimize infection management in pediatric patients.&#13;
Conclusion: Managing MP infections in a post-pandemic world requires continuous surveillance, advanced diagnostics, and adaptive treatment strategies. The increasing prevalence of MRMP underscores the need for alternative therapeutic options and robust antimicrobial stewardship. Future research should focus on predictive factors for treatment response, novel drug development, and the long-term impact of epidemiological shifts on respiratory infections.</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>04</month>
          <day>01</day>
          <year>2025</year>
        </publication_date>
        <pages>
          <first_page>392</first_page>
          <last_page>404</last_page>
        </pages>
        <ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators">
          <ai:license_ref>https://creativecommons.org/licenses/by/4.0</ai:license_ref>
        </ai:program>
        <doi_data>
          <doi>10.61386/imj.v18i2.684</doi>
          <resource>https://ibommedicaljournal.org/index.php/imjhome/article/view/684</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>https://ibommedicaljournal.org/index.php/imjhome/article/download/684/1367</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://ibommedicaljournal.org/index.php/imjhome/article/download/684/1367</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>